Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Onconova Therapeutics, Inc. - Common Stock (NQ: ONTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Onconova Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Onconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics: Q1 Earnings Insights
Via Benzinga
Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
Conference call and live webcast at 4:30 p.m. ET today 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Earnings Outlook For Onconova Therapeutics
Via Benzinga
Preview: Onconova Therapeutics's Earnings
Via Benzinga
Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023
Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform. 
Via Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting
Data further characterize narazaciclib’s mechanism of action and show its anti-cancer activity comparing favorably to that of FDA-approved CDK 4/6 inhibitors 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
Conference call and live webcast at 4:30 p.m. ET today 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics Announces Upcoming Poster Presentations at the AACR Annual Meeting
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics Presents Preclinical Data Characterizing Rigosertib’s Mechanisms of Action at the AACR Targeting RAS Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series
From Onconova Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS